tiprankstipranks
Trending News
More News >
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171

Compare CARsgen Therapeutics Holdings Ltd. (2171) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$8.96B
-15.59
53.77%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$12.33
HK$13.69B
-48.42
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Everest Medicines Ltd.
HK$51.50
HK$13.78B
-17.77
-3.33%
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$17.42B
121.79
457.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.93B
14.42
4.52%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.50
5.30
51.96%
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:1952
Everest Medicines Ltd.
38.96
-2.19
-5.32%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
43.88
35.97
454.74%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
25.92
2.75
11.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts